Rating Change
UBS reiterated its Buy rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on August 17, 2026.
reiterateNASDAQ:ACAD
UBS Reiterates Buy Rating on ACADIA Pharmaceuticals Inc. (ACAD)
UBS reiterated its Buy rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on August 17, 2026.
At publication ·
What changed
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) · reiterate
- Firm
- UBS
- Rating
- Buy to Buy
- Price at event
- $28.83
- Market capitalization
- $4.2B
At a glance
Key takeaways
- UBS reiterated a Buy rating on ACADIA Pharmaceuticals (ACAD) on August 17, 2026, with the stock trading at $28.83 and a market capitalization of $4.2 billion.
Market Context
ACADIA Pharmaceuticals Inc. operates in the Healthcare sector. The stock currently trades at $28.83 with a market capitalization of $4.2B.
Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for ACADIA Pharmaceuticals Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for ACADIA Pharmaceuticals Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 17, 2026 | UBS | Buy | N/A |
| Aug 12, 2026 | Needham | Buy | N/A |
| Aug 10, 2026 | Citigroup | Buy | N/A |
| Aug 05, 2026 | Citizens | Market Outperform | N/A |
| Aug 05, 2026 | RBC Capital | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View ACAD Stock Page
Frequently Asked Questions
What does the Buy rating mean for ACAD?
A rating of Buy from UBS reflects the analyst's outlook on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ACAD forecast page.